Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Exelixis Looks To Early-Stage Option Rights As Low-Risk Pipeline Expansion Play
Nov 02 2022
•
By
Joseph Haas
Exelixis is maintaining a busy pace with Cabometyx and two new deals • Source: Shutterstock
More from Deals
More from Business